News

After reviewing a record 38,000 comments on proposed rules limiting telehealth prescriptions for buprenorphine and other controlled substances after the COVID-19 public health emergency, the Drug Enforcement Administration and Department of Health and Human Services “have decided to extend the current flexibilities while we work to find a way forward to give Americans that access with appropriate safeguards,” the DEA announced May 3.

ProMedica’s approach to integrating social determinants of health “is designed to offer a helping hand, not a prescribed intervention,” writes the health system’s director of community impact in Michigan.

Pregnant people with opioid use disorder are more likely to receive buprenorphine (a recommended treatment) if they are older, white and have public insurance.

AHA May 1 released a customizable video and other social media resources to help hospitals and health systems celebrate National Hospital Week.

The Centers for Medicare & Medicaid Services May 1 announced two investigations of

AHA opposes the Centers for Medicare & Medicaid Services’ proposal to limit patient days when calculating Medicare Disproportionate Share Hospital payments for patients eligible for Medicaid benefits under a Section 1115 demonstration project, which it said could devastate access to care for lower-income populations by curtailing resources used to finance health care in historically marginalized communities.

The Government Accountability Office May 1 named six new members to the Medicaid and CHIP Payment and Access Commission, which advises Congress on issues affecting Medicaid and the Children’s Health Insurance Program.

The Food and Drug Administration April 28 authorized a fourth Pfizer COVID-19 bivalent vaccine dose at least one month after the third dose for certain immunocompromised children aged six months through 4.

The Food and Drug Administration last week alerted health care providers and laboratory personnel to a cybersecurity vulnerability affecting the Universal Copy Service software in certain Illumina medical devices used to sequence DNA for clinical diagnostic use or research.

May is Mental Health Awareness Month. It’s an opportunity to note the progress we’ve made addressing behavioral health issues and delivering quality care, and to assess and take action to tackle the significant work that remains.

Forty-nine cities and states with the highest HIV transmission rates yesterday received between $2 million and $17 million each in fiscal year 2023 grants from the Health Resources and Services Administration to diagnose, treat and prevent new HIV infections as part of a Department of Health and Human Services initiative to reduce new infections at least 90% by 2030.

Join AHA Community Health Improvement and hospitals and health systems throughout the country June 12-18 in recognizing the people and organizations that are improving individual and community health and well-being.

AHA this week joined 30 other organizations in voicing support for the Chronic Care Management Improvement Act, legislation that would remove the 20% cost-sharing requirement for Chronic Care Management services under the Medicare Physician Fee Schedule.

By taking a holistic approach and addressing the social determinants of health, ProMedica is working to improve the health and well-being of individuals and communities in Northwest Ohio and Southeast Michigan.

We must stabilize hospitals’ finances to ensure access to patient care. We must strengthen the health care workforce.

AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic.

AHA on May 8 will release “Rebuilding a New Minneapolis: From Tragedy to Transformation,” a short film in which six Minneapolis hospital leaders discuss how the summer of 2020 shaped the future of their work, and how that moment in time impacted their organization.

The Food and Drug Administration approved the first fecal microbiota product taken orally to prevent recurrent C. difficile infection. 

In a study of adults hospitalized between February 2022 and February 2023, when the omicron variant predominated, monovalent mRNA vaccination was 76% effective at preventing COVID-19-associated invasive mechanical ventilation and death up to 6 months after the last dose and 56% effective at least one year after the last dose, the Centers for Disease Control and Prevention reported. 

The Centers for Medicare & Medicaid Services released two proposed rules focused on ensuring access to services for Medicaid and Children’s Health Insurance Program beneficiaries across fee-for-service and managed care delivery systems.